Cancer therapy : differentiation, immunomodulation, and angiogenesis / edited by Natale D'Alessandro, Institute of Pharmacology, Piazza XX Settembre 4, 98100 Messina, Italy, Enrico Mihich, Grace Cancer Drug Center, Department of Experimental Therapeutics, Roswell Park Center Institute, Elm and Carlton Streets, Buffalo, NY 14263, USA, Luciano Rausa, Faculty of Medicine, Policlinic of the University "P. Giaccone", Via del Vespro 129, 90127 Palermo, Italy, Haim Tapiero, Laboatoire de Pharmacologie Cellulaire & Moleculaire, ICIG, Hopital Pual-Brousse, 14 av. Paul-Vailant-Coulturier, 94800 Villejuif, France, Thomas R. Tritton, University of Vermont, School of Medicine, Burlington, VT 05405, USA.
Provided here is a comprehensive examination of the basic and clinical condition of three innovative and promising approaches to cancer therapy, which may support or even substitute chemotherapy: differentiation, immunomodulation, and inhibition of angiogenesis. Differentiation shouldnormalize neopl...
Saved in:
| Online Access: |
Full Text (via Springer) |
|---|---|
| Corporate Authors: | , |
| Other Authors: | , , , , |
| Format: | Conference Proceeding eBook |
| Language: | English |
| Published: |
Berlin ; New York :
Springer-Verlag,
[1993]
|
| Series: | NATO ASI series. Cell biology ;
vol. 75. |
| Subjects: |
MARC
| LEADER | 00000cam a2200000xi 4500 | ||
|---|---|---|---|
| 001 | b8017350 | ||
| 006 | m o d | ||
| 007 | cr ||||||||||| | ||
| 008 | 131114s1993 gw a ob 101 0 eng d | ||
| 005 | 20240418150310.9 | ||
| 019 | |a 968487867 |a 1153307094 | ||
| 020 | |a 9783642846137 |q (electronic bk.) | ||
| 020 | |a 3642846130 |q (electronic bk.) | ||
| 020 | |z 9783642846151 | ||
| 020 | |z 3540546030 | ||
| 020 | |z 9783540546030 | ||
| 020 | |z 0387546030 | ||
| 020 | |z 9780387546032 | ||
| 020 | |z 3642846157 | ||
| 024 | 7 | |a 10.1007/978-3-642-84613-7 | |
| 035 | |a (OCoLC)spr862964315 | ||
| 035 | |a (OCoLC)862964315 |z (OCoLC)968487867 |z (OCoLC)1153307094 | ||
| 037 | |a spr978-3-642-84613-7 | ||
| 040 | |a GW5XE |b eng |e rda |e pn |c GW5XE |d OCLCO |d OCLCF |d OCL |d OCLCO |d OCLCQ |d OCLCO |d OCLCQ |d OCLCO |d YDX |d UAB |d COO |d OCLCQ |d OCLCO |d OCLCQ |d AU@ |d LEAUB |d OCLCO |d OCLCQ |d OCLCA |d INARC |d EBLCP |d OCLCO |d OCLCQ | ||
| 049 | |a GWRE | ||
| 050 | 4 | |a RC271.D53 |b C36 1993eb | |
| 245 | 0 | 0 | |a Cancer therapy : |b differentiation, immunomodulation, and angiogenesis / |c edited by Natale D'Alessandro, Institute of Pharmacology, Piazza XX Settembre 4, 98100 Messina, Italy, Enrico Mihich, Grace Cancer Drug Center, Department of Experimental Therapeutics, Roswell Park Center Institute, Elm and Carlton Streets, Buffalo, NY 14263, USA, Luciano Rausa, Faculty of Medicine, Policlinic of the University "P. Giaccone", Via del Vespro 129, 90127 Palermo, Italy, Haim Tapiero, Laboatoire de Pharmacologie Cellulaire & Moleculaire, ICIG, Hopital Pual-Brousse, 14 av. Paul-Vailant-Coulturier, 94800 Villejuif, France, Thomas R. Tritton, University of Vermont, School of Medicine, Burlington, VT 05405, USA. |
| 264 | 1 | |a Berlin ; |a New York : |b Springer-Verlag, |c [1993] | |
| 264 | 4 | |c ©1993. | |
| 300 | |a 1 online resource (xi, 288 pages) : |b illustrations. | ||
| 336 | |a text |b txt |2 rdacontent. | ||
| 337 | |a computer |b c |2 rdamedia. | ||
| 338 | |a online resource |b cr |2 rdacarrier. | ||
| 490 | 1 | |a NATO ASI series. Series H, Cell biology ; |v vol. 75. | |
| 500 | |a "Proceedings of the NATO Advanced Study Institute on Specific Approaches in Cancer Therapy: Differentiation, Immunomodulation, and Angiogenesis held at Erice, Italy, October 17-27, 1992"--Title page verso. | ||
| 500 | |a "Published in cooperation with NATO Scientific Affairs Division." | ||
| 504 | |a Includes bibliographical references and index. | ||
| 505 | 0 | |a Colon cancer cell differentiation as related to methotrexate and 5-fluorouracil resistance -- The control of cell multiplication and differentiation in human myelomonocytic cells -- Signal transduction through the Epstein-Barr virus receptor in human B lymphocytes -- Signal transduction mechanisms as a target for cancer chemotherapy -- Therapeutic approaches for colon cancer based on transcriptional regulation of specific growth factors -- Interferon regulation of differentiation and mechanisms -- Induction of tumor cell differentiation as a mechanism of action of DNA-specific antitumor agents -- ATRA therapy in acute promyelocytic leukemia. A model for differentiation therapy -- Hemin is transported in human leukemia K562 cells and interacts with DNA sequences -- Immunomodulation by anticancer drugs in therapeutics -- Differential effects of low doses of structurally different anthracyclines on immunoglobulin production by mouse hybridoma B cells -- Chemical xenogenization of experimental tumors by antineoplastic drugs -- Reversal of drug resistance: synergistic anti-tumor cytotoxic activity by combination treatment with drug and TNF or toxins -- Immunomodulation in cancer patients treated with interleukin-2. Induction of non-specific and specific immune responses -- Potential role of tumor cell antigen modulation in cancer immunotherapy -- Effects of tumor necrosis factor-alpha on growth and doxorubicin sensitivity of multidrug resistant tumor cell lines -- Activation of macrophages by treatment of rat peritoneal cells with photofrin II and He-Ne laser 209 -- Synergistic interaction between simvastatin and antineoplastic drugs on glioma cell growth -- CNS and cardiovascular effects of TNF-alpha -- Angiogenesis and angiogenesis factors in stages of carcinogenesis -- Cytokine regulation of tumor-associated macrophages: therapeutic implications -- The mechanism of lectin-mediated adhesion of human ovarian carcinoma cells -- Inhibitory effect of suramin and heparin-like drugs on experimental angiogenesis -- Role of gangliosides in the modulation of the angiogenic response. | |
| 520 | |a Provided here is a comprehensive examination of the basic and clinical condition of three innovative and promising approaches to cancer therapy, which may support or even substitute chemotherapy: differentiation, immunomodulation, and inhibition of angiogenesis. Differentiation shouldnormalize neoplastic cells and make them compatible with the host. Its feasibility with retinoids, interferons, chemotherapeutic and other agents is discussed. Modulation by biological agents, cytotoxic effector cells and drugs is considered in attempts to boost endogenous antitumour defenses and/or to render neoplastic cells more susceptible to the immune attack of the host. Finally, the important aspect of interfering with tumour blood vessel development and function is taken into account. Consideringthe importance that chemotherapy has in cancer treatment and in view of a more and more integrated strategy, the relationship between the aforementioned approaches and chemotherapeutic agents and chemoresistance is treated in detail. | ||
| 588 | 0 | |a Print version record. | |
| 650 | 0 | |a Cancer |x Differentiation therapy |v Congresses. | |
| 650 | 0 | |a Cancer |x Immunotherapy |v Congresses. |0 http://id.loc.gov/authorities/subjects/sh2009118244. | |
| 650 | 0 | |a Neovascularization |v Congresses. | |
| 650 | 0 | |a Biological response modifiers |x Therapeutic use |v Congresses. | |
| 650 | 7 | |a Biological response modifiers |x Therapeutic use. |2 fast |0 (OCoLC)fst00832315. | |
| 650 | 7 | |a Cancer |x Differentiation therapy. |2 fast |0 (OCoLC)fst00845351. | |
| 650 | 7 | |a Cancer |x Immunotherapy. |2 fast |0 (OCoLC)fst00845386. | |
| 650 | 7 | |a Neovascularization. |2 fast |0 (OCoLC)fst01035916. | |
| 655 | 7 | |a Conference papers and proceedings. |2 fast |0 (OCoLC)fst01423772. | |
| 700 | 1 | |a D'Alessandro, Natale, |d 1946- |e editor. |0 http://id.loc.gov/authorities/names/n93079935 |1 http://isni.org/isni/0000000081239478. | |
| 700 | 1 | |a Mihich, Enrico, |e editor. |0 http://id.loc.gov/authorities/names/n80073650 |1 http://isni.org/isni/0000000116224568. | |
| 700 | 1 | |a Rausa, L. |q (Luciano), |d 1932- |e editor. |0 http://id.loc.gov/authorities/names/n85321503 |1 http://isni.org/isni/0000000081816597. | |
| 700 | 1 | |a Tapiero, H. |q (Haïm), |e editor. |0 http://id.loc.gov/authorities/names/n89124133 |1 http://isni.org/isni/0000000378238396. | |
| 700 | 1 | |a Tritton, Thomas R., |e editor. |0 http://id.loc.gov/authorities/names/n87884916 |1 http://isni.org/isni/000000038392039X. | |
| 710 | 2 | |a North Atlantic Treaty Organization. |b Scientific Affairs Division, |e sponsoring body. |0 http://id.loc.gov/authorities/names/n79142766 |1 http://isni.org/isni/0000000121718909. | |
| 711 | 2 | |a NATO Advanced Study Institute on Specific Approaches in Cancer Therapy: Differentiation, Immunomodulation, and Angiogenesis |d (1992 : |c Erice, Italy) |0 http://id.loc.gov/authorities/names/n93079943. | |
| 776 | 0 | 8 | |i Print version: |t Cancer therapy |z 3540546030 |w (DLC) 93010491 |w (OCoLC)27974154. |
| 830 | 0 | |a NATO ASI series. |n Series H, |p Cell biology ; |v vol. 75. |0 http://id.loc.gov/authorities/names/n86747101. | |
| 856 | 4 | 0 | |u https://colorado.idm.oclc.org/login?url=https://link.springer.com/10.1007/978-3-642-84613-7 |z Full Text (via Springer) |
| 907 | |a .b80173500 |b 12-01-21 |c 06-02-15 | ||
| 998 | |a web |b 11-30-21 |c b |d b |e - |f eng |g gw |h 0 |i 1 | ||
| 907 | |a .b80173500 |b 11-30-21 |c 06-02-15 | ||
| 944 | |a MARS - RDA ENRICHED | ||
| 915 | |a - | ||
| 956 | |a Springer e-books | ||
| 956 | |b Springer Nature - Springer Book Archive - Biomedicine and Life Sciences | ||
| 956 | |b Springer Nature - Springer Book Archive - Biomedicine and Life Sciences | ||
| 956 | |a Biomedicine & Life Sciences | ||
| 956 | |a Springer e-books: Archive | ||
| 999 | f | f | |i e9753ed3-f008-588a-bec8-264eaa81f0be |s 8f8220e9-0c12-546f-a4ab-72b47951c19c |
| 952 | f | f | |p Can circulate |a University of Colorado Boulder |b Online |c Online |d Online |e RC271.D53 C36 1993eb |h Library of Congress classification |i Ebooks, Prospector |n 1 |